[go: up one dir, main page]

GB9526560D0 - Use of 2-Amino-Heterocycles - Google Patents

Use of 2-Amino-Heterocycles

Info

Publication number
GB9526560D0
GB9526560D0 GBGB9526560.9A GB9526560A GB9526560D0 GB 9526560 D0 GB9526560 D0 GB 9526560D0 GB 9526560 A GB9526560 A GB 9526560A GB 9526560 D0 GB9526560 D0 GB 9526560D0
Authority
GB
United Kingdom
Prior art keywords
heterocycles
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9526560.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Priority to GBGB9526560.9A priority Critical patent/GB9526560D0/en
Publication of GB9526560D0 publication Critical patent/GB9526560D0/en
Priority to PCT/EP1996/005643 priority patent/WO1997024328A1/en
Priority to AU13728/97A priority patent/AU1372897A/en
Pending legal-status Critical Current

Links

GBGB9526560.9A 1995-12-27 1995-12-27 Use of 2-Amino-Heterocycles Pending GB9526560D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9526560.9A GB9526560D0 (en) 1995-12-27 1995-12-27 Use of 2-Amino-Heterocycles
PCT/EP1996/005643 WO1997024328A1 (en) 1995-12-27 1996-12-16 2-amino-heterocycles and therapeutic uses therefor
AU13728/97A AU1372897A (en) 1995-12-27 1996-12-16 2-amino-heterocycles and therapeutic uses therefor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9526560.9A GB9526560D0 (en) 1995-12-27 1995-12-27 Use of 2-Amino-Heterocycles

Publications (1)

Publication Number Publication Date
GB9526560D0 true GB9526560D0 (en) 1996-02-28

Family

ID=10786100

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9526560.9A Pending GB9526560D0 (en) 1995-12-27 1995-12-27 Use of 2-Amino-Heterocycles

Country Status (3)

Country Link
AU (1) AU1372897A (en)
GB (1) GB9526560D0 (en)
WO (1) WO1997024328A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
US6794392B1 (en) 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
US6951862B2 (en) 1998-06-30 2005-10-04 Neuromed Technologies, Inc. Calcium channel blockers comprising two benzhydril moieties
US7186726B2 (en) 1998-06-30 2007-03-06 Neuromed Pharmaceuticals Ltd. Preferentially substituted calcium channel blockers
KR20010112408A (en) * 1999-04-07 2001-12-20 모리타 다카카즈 N-Substituted-N'-Substituted urea derivative and use thereof as TNF-αproduction inhibitor
GB0010955D0 (en) * 2000-05-05 2000-06-28 Novartis Ag Organic compounds
CN1324012C (en) 2000-05-31 2007-07-04 参天制药株式会社 TNF-alpha prodn. inhibitors
US6372795B1 (en) * 2000-06-30 2002-04-16 Unilever Home And Personal Care Usa, A Division Of Conopco, Inc. Cosmetic compositions containing substituted amide derivatives
CN1678311A (en) 2002-06-27 2005-10-05 诺沃挪第克公司 Arylcarbonyl derivatives useful as therapeutic agents
CN101130526B (en) * 2002-06-27 2013-07-10 诺沃挪第克公司 Aryl carbonyl derivatives as therapeutic agents
MXPA05000130A (en) 2002-06-27 2005-02-17 Novo Nordisk As Aryl carbonyl derivatives as therapeutic agents.
EP1829858A3 (en) 2002-08-30 2007-10-03 Japan Tobacco, Inc. Dibenzylamine compounds and pharmaceutical use thereof
US8309562B2 (en) 2003-07-03 2012-11-13 Myrexis, Inc. Compounds and therapeutical use thereof
AU2004253967B2 (en) 2003-07-03 2010-02-18 Cytovia, Inc. 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
PL1723128T3 (en) 2004-01-06 2013-04-30 Novo Nordisk As Heteroaryl-ureas and their use as glucokinase activators
AU2005231872A1 (en) * 2004-04-09 2005-10-20 Neuromed Pharmaceuticals Ltd. Diarylamine derivatives as calcium channel blockers
US8258145B2 (en) 2005-01-03 2012-09-04 Myrexis, Inc. Method of treating brain cancer
CA2592900A1 (en) 2005-01-03 2006-07-13 Myriad Genetics Inc. Nitrogen containing bicyclic compounds and therapeutical use thereof
ATE547396T1 (en) 2005-07-08 2012-03-15 Novo Nordisk As DICYCLOALKYLCARBAMOYL UREAS AS GLUCOKINASE ACTIVATORS
US7884210B2 (en) 2005-07-14 2011-02-08 Novo Nordisk A/S Ureido-thiazole glucokinase activators
DK2076508T3 (en) 2006-10-18 2011-02-21 Pfizer Prod Inc The biaryl ether urea compounds
WO2008117862A1 (en) * 2007-03-28 2008-10-02 Santen Pharmaceutical Co., Ltd. Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure
CA2744383C (en) 2008-11-21 2017-04-25 High Point Pharmaceuticals, Llc Adamantyl benzamide compounds
US8513430B2 (en) 2010-07-27 2013-08-20 High Point Pharmaceuticals, Llc Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta HSD1 modulators
TW201217335A (en) * 2010-09-07 2012-05-01 Taiho Pharmaceutical Co Ltd Prostaglandin d synthase inhibitory piperidine compounds
ES2846833T3 (en) 2016-07-18 2021-07-29 Janssen Pharmaceutica Nv PET imaging ligands
ES2862374T3 (en) 2016-12-28 2021-10-07 Minoryx Therapeutics S L Isoquinoline compounds, methods for their preparation and therapeutic uses of the same in conditions associated with the alteration of beta galactosidase activity
EP4487909A3 (en) 2018-06-12 2025-03-19 vTv Therapeutics LLC Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
MX2021016005A (en) * 2019-06-26 2022-06-16 Enyo Pharma Tertiary amine derivatives and their uses for treating a viral infection.
US12391658B2 (en) 2020-02-18 2025-08-19 Vtv Therapeutics Llc Sulfoxide and sulfone glucokinase activators and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4782071A (en) * 1986-11-03 1988-11-01 Warner-Lambert Company Tetrasubstituted urea cholinergic agents
US5250693A (en) * 1987-07-31 1993-10-05 American Home Products Corporation Quinolinylmethoxy naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents
EP0401168A3 (en) * 1989-06-02 1991-11-06 Ciba-Geigy Ag Herbicides

Also Published As

Publication number Publication date
AU1372897A (en) 1997-07-28
WO1997024328A1 (en) 1997-07-10

Similar Documents

Publication Publication Date Title
GB9526560D0 (en) Use of 2-Amino-Heterocycles
GB2298422B (en) Compounds and their use
PL322277A1 (en) Derivatives of pyrazol-4-ylobenzoyl
SI1445259T1 (en) Use of crystal forms of 2-methyl-thieno-benzodiazepine
IL118825A0 (en) 6-dimethylaminomethyl -1- phenyl-cyclohexane compounds their preparation and use
IL119864A0 (en) 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-OL compounds their preparation and use
PL324451A1 (en) Derivatives of diphenylmethylenepiperidine
GB9512290D0 (en) Uses of polyhexanide
IL116924A (en) Preparation of n-aryl - and n-hetarylhydroxylamines
ZA96725B (en) Use of phenyclyclohexylcarboxamides
HU9700071D0 (en) Use of muramilpeptides
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
GB9508637D0 (en) New use
IL117786A (en) Preparation of alpha-bisoximes
IL118225A0 (en) Use of felodipine
IL117844A0 (en) Use of (s)-adenosyl-l-methionine
ZA962440B (en) Destressing of railtracks
SG64924A1 (en) Inhibiting photodecompostion of 3-substituted-2- oxindoles
PL313849A1 (en) Beta-aminoesters of o-hydrobenzylamides
IL115554A0 (en) Earthquake-proofing of structures
HRP950468A2 (en) New medicine - combination of components
GB9514072D0 (en) Preparation of thionucleosides
GB9505071D0 (en) Use
GB9520121D0 (en) Use
GB9520119D0 (en) Use